Who and why do researchers opt to publish in post-publication peer review platforms? - findings from a review and survey of F1000 Research

Author:

Kirkham JamieORCID,Moher DavidORCID

Abstract

Background:  Preprint servers and alternative publication platforms enable authors to accelerate the dissemination of their research.  In recent years there has been an exponential increase in the use of such servers and platforms in the biomedical sciences, although little is known about who, why and what experiences researchers have with publishing on such platforms.  In this article we explore one of these alternative publication platforms, F1000 Research, which offers immediate publication followed by post-publication peer review.  Methods: From an unselected cohort of articles published between 13th July 2012 and 30th November 2017 in F1000 Research, we provided a summary of who and what was published on this platform and calculated the percentage of published articles that had been indexed on a bibliographic database (PubMed) following successful post-publication peer review.  We also surveyed corresponding authors to further understand the rationale and experiences of those that have published using this platform.       Results: A total of 1865 articles had been published in the study cohort period, of which 80% (n=1488) had successfully undergone peer review and were indexed on PubMed within a minimum period of six months since first publication. Nearly three-quarters of articles passed the peer review process with their initial submission.  Survey responses were received from 296 corresponding authors. Open access, open peer review and the speed of publication were the three main reasons why authors opted to publish with F1000 Research.     Conclusions: Many who published with F1000 Research had a positive experience and indicated that they would publish again with this same platform in the future.  Nevertheless, there remained some concerns about the peer review process and the quality of the articles that were published.

Publisher

F1000 Research Ltd

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3